Overview Latest Regional Industry Featured Multimedia Other Languages Public Company News
The World's Largest 36,000L Biomanufacturing Line Using Single-use Bioreactors Launches GMP Operation at WuXi Biologics 2021-02-09 08:25
Proxima Ventures and Co-win Ventures invest in Bioelectronica® Corporation to accelerate pharmaceutical discovery and development 2021-02-09 04:46
Longevity Acquisition Corporation Announces 4D pharma Clinical Trial Collaboration and Supply Agreement for the Treatment of Locally Advanced or Metastatic Urothelial Carcinoma 2021-02-08 21:00
Inova Appoints Claude Basset as Chief Product Officer 2021-02-08 16:00
Orpha Labs AG Initiates Compassionate Use Program for ORL-101 in Leukocyte Adhesion Deficiency Type II (LAD-II) 2021-02-08 15:00
I-Mab Announces Multiple Clinical Advancements of Its Differentiated CD73 Antibody Uliledlimab in China and the U.S. 2021-02-05 21:00
I-Mab Announces First Patient Dosed in Phase 2 Clinical Trial of TJ107 in Glioblastoma Multiforme in China 2021-02-04 21:00
Covid-19 Drug Duo Achievements: GoldenBiotech's New Drug Antroquinonol (HOCENA) Trial Receives Positive Response from DMC Review and Licenses for 4 Countries 2021-02-04 20:30
Eucure Biopharma Announces Encouraging Antitumor Activity of Its anti-CD40 Antibody in PD-1 Refractory Ocular Melanoma when Combined with Junshi Biosciences' Toripalimab 2021-02-03 23:45
Ping An Healthcare and Technology Company Limited posts revenue of RMB 6,866 million in 2020 2021-02-03 01:03
Dyadic and TurtleTree Scientific enter strategic partnership 2021-02-02 22:00
Ascentage Pharma Released Preclinical Results of MDM2-p53 Inhibitor APG-115 in an Oral Presentation at WCLC 2020, Demonstrating Therapeutic Potential in STK11-Mutant Non-Small Cell Lung Cancer 2021-02-02 17:24
Inmagene launched U.S. subsidiary; Dr. Jean-Louis Saillot joined the company. 2021-02-02 14:48
Crafoord Laureate discovered the explanation for mysterious fevers 2021-02-01 21:06
Clover Biopharmaceuticals Announces Publication of Phase 1 Clinical Trial Data for its Adjuvanted COVID-19 Vaccine Candidates in The Lancet 2021-02-01 14:00
Clover and Dynavax Announce Planned Global Phase 2/3 Efficacy Trial of Adjuvanted COVID-19 Vaccine Candidate 2021-02-01 14:00
Seegene develops world first COVID-19 variant test capable of identifying origins of virus variants 2021-02-01 13:05
RedHill Biopharma Announces Positive DSMB Futility Review for Phase 2/3 COVID-19 Study of Opaganib 2021-01-29 20:26
Ascentage Pharma Announces the Fifth Orphan Drug Designation Granted to Bcl-2 Inhibitor APG-2575 by the US FDA, and the Tenth Obtained by the Company 2021-01-29 08:29
Alfasigma to expand its digital footprint 2021-01-29 00:27
1 259 260 261 262 263 451